Home
BHC
BHC News

Latest Bausch Health Companies Inc. (BHC) News on July 27, 2024

Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?

Zacks

a day ago

Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?

MT Newswires

2 days ago

Truist Adjusts Bausch Health Companies' PT to $7 From $8, Maintains Hold Rating

Bausch Health Stock Swings Wildly as it Addresses Report It's Considering Bankruptcy

Investopedia

2 days ago

Bausch Health Stock Swings Wildly as it Addresses Report It's Considering Bankruptcy

MT Newswires

2 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

2 days ago

Sector Update: Health Care

MT Newswires

2 days ago

Bausch Health Says Not Considering Bankruptcy as it Responds to Stock Plunge

MT Newswires

2 days ago

Update: Bausch Health Denies Bankruptcy Rumors

MT Newswires

2 days ago

Bausch Health Denies Bankruptcy Rumors

Canadian Investment Regulatory Organization Trade Resumption - BHC

CNW Group

2 days ago

Canadian Investment Regulatory Organization Trade Resumption - BHC

Bausch Health Responds to Market Rumors

ACCESSWIRE

2 days ago

Bausch Health Responds to Market Rumors

Canadian Investment Regulatory Organization Trading Halt - BHC

CNW Group

2 days ago

Canadian Investment Regulatory Organization Trading Halt - BHC

Nanotechnology in medicine: Who are the leading public companies?

Medical Device Network

4 days ago

Nanotechnology in medicine: Who are the leading public companies?

MT Newswires

4 days ago

RBC Previews Bausch + Lomb's Q2 -- Raises Target to US$20

MT Newswires

4 days ago

Bausch + Lomb Q2 Revenue Expected to Rise 15%, RBC Says

MT Newswires

5 days ago

RBC Raises Price Target on Bausch + Lomb to $20 From $18, Keeps Outperform Rating

MT Newswires

7 days ago

Bausch Health Appoints Jean-Jacques Charhon as CFO

MT Newswires

8 days ago

Bausch Health Appoints Two New Members of Executive Leadership Team

ACCESSWIRE

8 days ago

Bausch Health Welcomes Two New Members to the Executive Leadership Team

Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024

ACCESSWIRE

16 days ago

Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024

MT Newswires

17 days ago

--Raymond James Initiates Bausch Health at Market Perform Rating

MT Newswires

17 days ago

Raymond James Initiates Bausch + Lomb at Outperform Rating With $19 Price Target

MT Newswires

18 days ago

RBC Capital on Bausch + Lomb's Miebo, Xiidra, Prescription Numbers

MT Newswires

a month ago

Bausch Health Sues Norwich for Patent Infringement Over Application for Generic Version of IBS Drug

Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals

ACCESSWIRE

a month ago

Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals

With 63% ownership of the shares, Bausch Health Companies Inc. (NYSE:BHC) is heavily dominated by institutional owners

Simply Wall St.

a month ago

With 63% ownership of the shares, Bausch Health Companies Inc. (NYSE:BHC) is heavily dominated by institutional owners

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences

ACCESSWIRE

a month ago

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences

Bausch + Lomb’s enVista Envy IOL obtains Health Canada approval

Medical Device Network

2 months ago

Bausch + Lomb’s enVista Envy IOL obtains Health Canada approval

MT Newswires

2 months ago

Bausch + Lomb's New Intraocular Lens Approved by Health Canada

MT Newswires

2 months ago

Bausch Health Announces Wider Public Drug Plan Coverage for Uceris in Canada

Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults

ACCESSWIRE

2 months ago

Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024

ACCESSWIRE

2 months ago

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024

MT Newswires

2 months ago

RBC Notes Updates on Bausch Xifaxan Patent Litigation with Norwich

Bausch Health Announces 2024 Annual Meeting of Shareholder Results

ACCESSWIRE

2 months ago

Bausch Health Announces 2024 Annual Meeting of Shareholder Results

MT Newswires

2 months ago

Bausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN Matters

Bausch Health Announces Updates Related to Norwich XIFAXAN Matters

ACCESSWIRE

2 months ago

Bausch Health Announces Updates Related to Norwich XIFAXAN Matters

MT Newswires

2 months ago

RBC Noes Bausch Health Filing For Rehearing in Appellate Court

Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)

ACCESSWIRE

3 months ago

Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)

MT Newswires

3 months ago

Bausch + Lomb Shares Rise After Morgan Stanley Upgrade

MT Newswires

3 months ago

Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16

Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week

Simply Wall St.

3 months ago

Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week

Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript

Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript

MT Newswires

3 months ago

RBC Lowers Bausch Health Target to US$10, Maintains Sector Perform

Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall

Zacks

3 months ago

Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall

Why Bausch Health Companies Stock Dived by More Than 7% Today

Motley Fool

3 months ago

Why Bausch Health Companies Stock Dived by More Than 7% Today

MT Newswires

3 months ago

RBC Capital Reviews Bausch + Lomb's Q1 Results

MT Newswires

3 months ago

Bausch Health Shares Fall Following Q1 Results

MT Newswires

3 months ago

Deutsche Bank Adjusts Bausch + Lomb Price Target to $14 From $18, Maintains Hold Rating

Reuters

3 months ago

CANADA STOCKS-Toronto stocks rise on energy boost, rate-cut optimism

GuruFocus.com

3 months ago

Bausch Health Companies Inc Reports Q1 2024 Earnings: A Detailed Analysis Compared to Analyst ...

Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates

Zacks

3 months ago

Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates

MT Newswires

3 months ago

Bausch Health Q1 Net Loss Narrows on Higher Revenue, Confirms 2024 Revenue Guidance

MT Newswires

3 months ago

Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year

MT Newswires

3 months ago

Bausch + Lomb Q1 Loss Widens, Revenue Increases

MT Newswires

3 months ago

Bausch + Lomb Q1 Net Loss Widens, But Revenue Higher; Raises 2024 Revenue Growth Guidance

Associated Press Finance

3 months ago

Bausch + Lomb: Q1 Earnings Snapshot

All You Need to Know About Bausch (BHC) Rating Upgrade to Buy

Zacks

3 months ago

All You Need to Know About Bausch (BHC) Rating Upgrade to Buy

MT Newswires

3 months ago

Bausch + Lomb Says Study Shows Improvements in Dry Eyes With Nutritional Supplement

Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline

Zacks

3 months ago

Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline

MT Newswires

3 months ago

Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

Zacks

3 months ago

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

MT Newswires

3 months ago

Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says

MT Newswires

3 months ago

RBC Cuts Bausch + Lomb Target to US$18, Reiterates Outperform, as Previews Q1

10 Best Healthcare Stocks to Buy Under $20

Insider Monkey

3 months ago

10 Best Healthcare Stocks to Buy Under $20

Bausch Health to Announce First-Quarter 2024 Results on May 2

ACCESSWIRE

3 months ago

Bausch Health to Announce First-Quarter 2024 Results on May 2

Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029

ACCESSWIRE

3 months ago

Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029

Reuters

3 months ago

Bausch wins US appeal to block Alvogen generic of diarrhea drug

Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?

Zacks

3 months ago

Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?

Canadian Investment Regulatory Organization Trade Resumption - BHC

CNW Group

3 months ago

Canadian Investment Regulatory Organization Trade Resumption - BHC

Canadian Investment Regulatory Organization Trading Halt - BHC

CNW Group

3 months ago

Canadian Investment Regulatory Organization Trading Halt - BHC

Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

ACCESSWIRE

4 months ago

Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

Reuters

4 months ago

CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision

Bausch (BHC) Starts Litigation Against Amneal for Xifaxan

Zacks

4 months ago

Bausch (BHC) Starts Litigation Against Amneal for Xifaxan

BLCO vs. AVTR: Which Stock Is the Better Value Option?

Zacks

4 months ago

BLCO vs. AVTR: Which Stock Is the Better Value Option?

Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals

ACCESSWIRE

4 months ago

Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals

/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/

CNW Group

4 months ago

/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/

Here's Why Bausch Health (BHC) is a Strong Momentum Stock

Zacks

4 months ago

Here's Why Bausch Health (BHC) is a Strong Momentum Stock

Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults

ACCESSWIRE

4 months ago

Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults

Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations

ACCESSWIRE

4 months ago

Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations

Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)

Simply Wall St.

4 months ago

Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)

The Enduring Losses Incurred by Carl Icahn’s 10 Activist Targets over the Long Term

Insider Monkey

4 months ago

The Enduring Losses Incurred by Carl Icahn’s 10 Activist Targets over the Long Term

Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?

Zacks

4 months ago

Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?

All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy

Zacks

4 months ago

All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy

BLCO or AVTR: Which Is the Better Value Stock Right Now?

Zacks

4 months ago

BLCO or AVTR: Which Is the Better Value Stock Right Now?

Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock

Zacks

4 months ago

Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock

Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term

Zacks

4 months ago

Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term

Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma

ACCESSWIRE

5 months ago

Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma

New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure

ACCESSWIRE

5 months ago

New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure

Bausch Health Companies to Present at Cowen Annual Health Care Conference

ACCESSWIRE

5 months ago

Bausch Health Companies to Present at Cowen Annual Health Care Conference

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

5 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Bausch + Lomb Corporation (NYSE:BLCO) Yearly Results: Here's What Analysts Are Forecasting For This Year

Simply Wall St.

5 months ago

Bausch + Lomb Corporation (NYSE:BLCO) Yearly Results: Here's What Analysts Are Forecasting For This Year

Bausch Health Companies Inc. (NYSE:BHC) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Bausch Health Companies Inc. (NYSE:BHC) Q4 2023 Earnings Call Transcript

Bausch (BHC) Q4 Earnings and Revenues Top Estimates

Zacks

5 months ago

Bausch (BHC) Q4 Earnings and Revenues Top Estimates

Bausch + Lomb Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

Bausch + Lomb Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Bausch + Lomb Corporation (NYSE:BLCO) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Bausch + Lomb Corporation (NYSE:BLCO) Q4 2023 Earnings Call Transcript

14 Best Canadian Stocks To Buy and Hold In 2024

Insider Monkey

5 months ago

14 Best Canadian Stocks To Buy and Hold In 2024

Bausch (BHC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

5 months ago

Bausch (BHC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Bausch Health (BHC) Surpasses Q4 Earnings and Revenue Estimates

Zacks

5 months ago

Bausch Health (BHC) Surpasses Q4 Earnings and Revenue Estimates

Bausch Health Companies Inc. Reports Revenue Growth Amidst Net Losses in Q4 and Full-Year 2023

GuruFocus.com

5 months ago

Bausch Health Companies Inc. Reports Revenue Growth Amidst Net Losses in Q4 and Full-Year 2023

Associated Press Finance

5 months ago

Bausch: Q4 Earnings Snapshot

Share on Social Networks: